
Sign up to save your podcasts
Or


Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.
By The Motley Fool4.7
16041,604 ratings
Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.

3,239 Listeners

1,498 Listeners

806 Listeners

941 Listeners

530 Listeners

1,182 Listeners

2,184 Listeners

825 Listeners

1,425 Listeners

1,052 Listeners

9,714 Listeners

195 Listeners

829 Listeners

84 Listeners

49 Listeners

1,024 Listeners

49 Listeners